Prospective, randomized trial comparing fluids and dobutamine optimization of oxygen delivery in high-risk surgical patients [ISRCTN42445141]
Available online http://ccforum.com/content/10/3/R72
Research
Vol 10 No 3
Open Access
Prospective, randomized trial comparing fluids and dobutamine
optimization of oxygen delivery in high-risk surgical patients
[ISRCTN42445141]
Suzana M Lobo, Francisco R Lobo, Carlos A Polachini, Daniela S Patini, Adriana E Yamamoto,
Neymar E de Oliveira, Patricia Serrano, Helder S Sanches, Marco A Spegiorin, Marcio M Queiroz,
Antonio C Christiano Jr, Elisangela F Savieiro, Paula A Alvarez, Silvia P Teixeira and
Geni S Cunrath
Division of Critical Care Medicine, Departments of Internal Medicine, Anesthesiology and Surgery, Medical School – FUNFARME and Hospital de
Base, São José do Rio Preto, São Paulo, Brazil
Corresponding author: Suzana M Lobo,
Received: 16 Mar 2006 Accepted: 6 Apr 2006 Published: 12 May 2006
Critical Care 2006, 10:R72 (doi:10.1186/cc4913)
This article is online at: http://ccforum.com/content/10/3/R72
© 2006 Lobo et al.; licensee BioMed Central Ltd.
This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0),
which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Abstract
Introduction Preventing perioperative tissue oxygen debt
contributes to a better postoperative recovery. Whether the
beneficial effects of fluids and inotropes during optimization of
the oxygen delivery index (DO2I) in high-risk patients submitted
to major surgeries are due to fluids, to inotropes, or to the
combination of the two is not known. We aimed to investigate
the effect of DO2I optimization with fluids or with fluids and
dobutamine on the 60-day hospital mortality and incidence of
complications.
Results The cardiovascular depression was an important
component in the perioperative period in this group of patients.
Cardiovascular complications in the postoperative period
occurred significantly more frequently in the volume group (13/
25, 52%) than in the dobutamine group (4/25, 16%) (relative
risk, 3.25; 95% confidence interval, 1.22–8.60; P < 0.05). The
60-day mortality rates were 28% in the volume group and 8% in
the dobutamine group (relative risk, 3.00; 95% confidence
interval, 0.67–13.46; not significant).
Methods A randomized and controlled trial was performed in 50
high-risk patients (elderly with coexistent pathologies)
undergoing major elective surgery. Therapy consisted of
pulmonary artery catheter-guided hemodynamic optimization
during the operation and 24 hours postoperatively using either
fluids alone (n = 25) or fluids and dobutamine (n = 25), aiming
to achieve supranormal values (DO2I > 600 ml/minute/m2).
Conclusion In patients with high risk of perioperative death,
pulmonary artery catheter-guided hemodynamic optimization
using dobutamine determines better outcomes, whereas fluids
alone increase the incidence of postoperative complications.
Introduction
Mortality is unacceptably high in certain groups of surgical
patients [1]. Advanced age, extensive surgical trauma, cancer,
blood transfusions, and poor nutritional state are conditions
reported to be associated with severe changes of the body's
defense mechanisms, making the patient highly susceptible to
morbidity and mortality [2-4]. Sepsis and multiple organ failure
remains the most common cause of death [5].
Some authors have shown that the optimization of the oxygen
delivery index (DO2I > 600 ml/minute/m2), guided by a pulmonary artery catheter, in the perioperative period of high-risk
patients determined better survival and less episodes of complications when initiated before the development of organ failure and when therapy produced differences in oxygen delivery
[5-11]. The term 'optimization' refers to therapeutic intervention mainly with fluids, inotropic drugs and red blood cells, aim-
CI = confidence interval; DO2I = oxygen delivery index; FiO2 = fraction of inspired oxygen; ICU = intensive care unit; LVSWI = left ventricular stroke
work index; MAP = mean arterial pressure; PaCO2 = partial pressure of carbon dioxide; PaO2 = partial pressure of oxygen; PAOP = pulmonary artery
occlusion pressure; RR = relative risk.
Page 1 of 11
(page number not for citation purposes)
Critical Care
Vol 10 No 3
Lobo et al.
ing at a better cardiovascular function anticipating the
increase in oxygen demand during surgery. The main objective
is to maintain tissue perfusion to minimize the hepatosplanchnic ischemia, thus assuring organic function.
fluids and dobutamine on the 60-day mortality in high-risk general surgery patients. The second outcome measure was the
incidence of complications, particularly cardiovascular
adverse events.
High-risk surgical patients often present a decreased intravascular volume prior to a surgical procedure due to various factors. The importance of fluid replacement in the perioperative
period cannot be underestimated [12]. Anesthetic induction
still results in increases in systemic vascular capacitance and,
to a certain extent, in myocardial depression. Patients with
chronic heart failure can face a series of events during prolonged surgery that may end in acute decompensation. Even
critically ill patients without preexisting myocardial contractile
dysfunction may sustain severe perioperative complications
with subsequent acute heart failure [13].
Materials and methods
In previous randomized controlled trials in high-risk surgical
patients, after the adequate recovery of volemia, either dobutamine or dopexamine have been used with the objective to
optimize the cardiac index and/or the oxygen delivery [6-10].
Older patients with existing cardiorespiratory illness undergoing major surgery have a reduced morbidity and mortality when
dobutamine is used to maximize oxygen transport [10]. Nevertheless, in certain groups of surgical patients, goal-directed
therapy using fluids alone improved the outcome [14-17]. Evidence that optimization of fluid therapy, in the absence of inotropes, reduces mortality in high-risk patients is not available.
The primary outcome measure of the present study was to
evaluate the effect of both DO2I optimization with fluids or with
This study, approved by the Institutional Review Board, was
carried out in the operating room and the intensive care unit
(ICU) (24 beds) of a tertiary hospital. The informed consent to
take part in the study was obtained from the patient or from
their closest relative. Patients undergoing elective surgeries
were admitted to the study if they assigned ≥ 3 points according to a risk scoring system (Table 1) adapted from American
College of Cardiology/American Heart Association guidelines
[18]. The exclusion criteria were refusal of consent, hemodynamic instability prior to surgery, congestive heart failure, presence of infection, acute myocardial ischemia prior to
enrolment, life expectancy lower than 60 days, and disseminated malignancy.
Measurements of hemodynamic and oxygenation
(...truncated)